comparemela.com

Latest Breaking News On - Aditum bio - Page 3 : comparemela.com

Eli Lilly to Buy Versanis Bio, Adding to Obesity Drug Pipeline

Lilly reached a deal to buy Versanis Bio, a privately held biotech which is testing a monoclonal antibody drug called bimagrumab as a new treatment for obesity.

Ruth gimenoEli lillyJosh nathan kazisVersanis bioAditum bioMichael vi dreamstimeAtlas ventureNovo nordiskSigilon therapeuticsArticle normalAnti depressantsHealthcare life sciencesSpecialized drugs medicationsHormone productsDiabetes drugsNew products services

Eli Lilly to acquire obesity drug maker Versanis for $1 9 billion

The deal is Eli Lilly's latest attempt to capitalize on the weight loss industry gold rush, which was sparked by demand for Novo Nordisk's Wegovy and Ozempic.

Aditum bioNovo nordisk wegovyEli lillyNovo nordiskCalifornia based versanisIndianapolis based eliBiotech and pharmaceuticalsHealth care industryEli lilly and coNovo nordiska sWeight managementMergers and acquisitionsBreaking newsBusiness news

Lilly to buy Versanis, adding to obesity drug pipeline

BioPharma

Nick williamsRuth gimenoAditum bioEli lillyNovo nordiskAtlas ventureDive briefDice therapeuticsSigilon therapeutics

Why Eli Lilly (LLY) Shares Are Surging Today - Eli Lilly (NYSE:LLY)

Eli Lilly And Company (NYSE: LLY) 

United statesVersanis bioAditum bioEli lillyRuth gimenoEli lilly and companyAtlas venture

Lilly to spend up to $1 93B to acquire Boston biopharmaceutical firm – Inside INdiana Business

Lilly to spend up to $1 93B to acquire Boston biopharmaceutical firm – Inside INdiana Business
insideindianabusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insideindianabusiness.com Daily Mail and Mail on Sunday newspapers.

United statesRuth gimenoEli lillyAditum bioVersanis bioEli lilly coNovo nordisk

vimarsana © 2020. All Rights Reserved.